CANNABIS
Vaporized cannabis improves pain in neuropathic pain disorders
J Pain. 2013 Feb;14(2):136-48. doi: 10.1016/j.jpain.2012.10.00939 adults with neuropathic pain conditions received low-dose vaporized cannabis, medium-dose vaporized cannabis and placebo in a random order. The primary outcome was pain intensity and secondary outcomes included the patient impression of global change, a neuropathic pain scale, allodynia, heat-pain threshold, and mood. Low and moderate-dose vaporized cannabis reduced pain intensity and most adverse events were mild to moderate.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
